Globally, over 600 million people are infected with the skin-penetrating threadworm, Strongyloides stercoralis, mostly in tropical and subtropical regions with poor sanitation infrastructure. Infections are treated with ivermectin, but some nematodes are starting to develop resistance to this first-line drug. UCLA biologists have discovered that the nematodes respond differently to carbon dioxide at different stages in their life cycle, which could help scientists find ways to prevent or cure infections by targeting the CO2-sensing pathway.